| Entry |
|
|---|
| Name |
HIV protease inhibitors |
|---|
| Class |
|
|---|
| Pathway map |
|
|---|
| Compound |
| D00427 | Ritonavir (JAN/USP/INN) |
| D00429 | Saquinavir (JAN/USP/INN) |
| D00894 | Amprenavir (JAN/USAN/INN) |
| D00897 | Indinavir sulfate (USP) |
| D00899 | Nelfinavir mesylate (USAN/INN) |
| D01160 | Saquinavir mesylate (USP) |
| D01276 | Atazanavir sulfate (JAN/USAN) |
| D01425 | Lopinavir (JAN/USP/INN) |
| D02861 | Indinavir sulfate ethanolate (JAN) |
| D02867 | Fosamprenavir calcium hydrate (JAN) |
| D03835 | Fosamprenavir calcium (USAN) |
| D03837 | Fosamprenavir sodium (USAN) |
| D03839 | Droxinavir hydrochloride (USAN) |
| D03843 | Tipranavir disodium (USAN) |
| D06478 | Darunavir ethanolate (JAN) |
|
|---|
| Reference |
|
|---|
| Authors |
Tanaka C, Kato R (eds). |
|---|
| Title |
[New Pharmacology (4th ed)] (In Japanese) |
|---|
| Journal |
Nankodo (2002) |
|---|
| Reference |
|
|---|
| Authors |
Wlodawer A, Vondrasek J. |
|---|
| Title |
Inhibitors of HIV-1 protease: a major success of structure-assisted drug design. |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Brik A, Wong CH. |
|---|
| Title |
HIV-1 protease: mechanism and drug discovery. |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Wynn GH, Zapor MJ, Smith BH, Wortmann G, Oesterheld JR, Armstrong SC, Cozza KL. |
|---|
| Title |
Antiretrovirals, part 1: overview, history, and focus on protease inhibitors. |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Sugiura W. |
|---|
| Title |
[Progress in antiretroviral drugs] |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Mimoto T, Imai J, Tanaka S, Hattori N, Kisanuki S, Akaji K, Kiso Y. |
|---|
| Title |
KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic. |
|---|
| Journal |
|
|---|
| LinkDB |
|
|---|
